Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
Clinical trial NCT01963598 · COMPLETED
Trial details
- NCT number
- NCT01963598
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2015-01-01
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.